Skip to main content
رجوع
ACLX logo

Arcellx, Inc.

جودة البيانات: 100%
ذروة شراء
ACLX
NASDAQ Healthcare Biotechnology
KWD 114.69
▲ KWD 0.09 (0.08%)
القيمة السوقية: 6.71B
نطاق اليوم
KWD 114.40 KWD 114.70
نطاق 52 أسبوعًا
KWD 47.86 KWD 114.91
حجم التداول
1,377,509
متوسط 50 يوم / 200 يوم
KWD 86.59 / KWD 77.34
الإغلاق السابق
KWD 114.60

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -29.3 0.3
P/B 16.7 2.9
ROE % -53.4 3.7
Net Margin % -1027.3 3.8
Rev Growth 5Y % 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 110.420 -3.7%
Low: KWD 82.000 High: KWD 120.000
ربحية السهم المستقبلية
-KWD 3.518
الإيرادات المقدّرة
87 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 3.874
KWD 1.354 – KWD 8.122
740 M 4
FY2028 KWD 0.335
-KWD 0.484 – KWD 1.219
460 M 10
FY2027 -KWD 1.610
-KWD 5.468 – KWD 1.858
270 M 10

النقاط الرئيسية

Debt/Equity of 0.24 — conservative balance sheet
Negative free cash flow of -212.59M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-79.35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-53.42%
ROIC-38.07%
Net Margin-1027.25%
Op. Margin-1135.61%

الأمان

Debt / Equity
0.24
Current Ratio4.44
Interest Coverage-10.45

التقييم

P/E Ratio
-29.30
P/B Ratio16.67
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -79.35% Revenue Growth (3Y) -55.05%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 22.29M Net Income (TTM) -228.93M
ROE -53.42% ROA -37.90%
Gross Margin 70.03% Operating Margin -1135.61%
Net Margin -1027.25% Free Cash Flow (TTM) -212.59M
ROIC -38.07% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.24 Current Ratio 4.44
Interest Coverage -10.45 Dividend Yield 0.00%
Valuation
P/E Ratio -29.30 P/B Ratio 16.67
P/S Ratio 300.95 PEG Ratio -0.15
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 6.71B Enterprise Value 6.72B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 22.29M 107.94M 110.32M 0.0 0.0
Net Income -228.93M -107.35M -70.69M -188.68M -64.97M
EPS (Diluted) -4.07 -2.00 -1.47 -4.28 -1.94
Gross Profit 15.61M 102.75M 110.32M -2.22M 0.0
Operating Income -253.08M -137.57M -89.88M -191.26M -65.02M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 603.99M 711.33M 825.13M 313.82M 128.78M
Total Liabilities 201.64M 256.54M 339.75M 108.86M 250.30M
Shareholders' Equity 402.35M 454.79M 485.38M 204.95M -121.52M
Total Debt 96.26M 54.08M 97.63M 88.13M 0.0
Cash & Equivalents 80.26M 105.68M 394.58M 64.18M 30.83M
Current Assets 462.18M 599.31M 716.36M 266.86M 112.81M
Current Liabilities 104.20M 125.41M 118.24M 56.69M 14.85M